The wider Nifty hit a low of 10,033.35 before finishing at 10,044.10, down 74.15 points or 0.73 per cent.
Investors were anxious concerned about the uncertainties over the timing of Us Federal Reserve rate hike, US policies under President Donald Trump, the upcoming French election and rising crude price that could impact inflation, going ahead. A weak closing in Asia tracking overnight losses in the US owing to all these unknowns triggered selling, brokers said.
TCS, Wipro and Infosys dropped by up to 4.47 per cent, dragging down the BSE IT index by 2.96 per cent
Investment announcement for $100 bn over 5 years likely.
HDFC, ONGC, Maruti Suzuki, HeroMoto Corp and Bajaj Auto gained the most on BSE Sensex
Maruti Suzuki fell 0.7% even after its March quarter profit grew by 15.8% to Rs 1,709 crore in Q4
The benchmark Sensex gained 4,642.84 points, or 16.%, while the broader NSE Nifty surged 1,572.85 points, or 18.20% during this period.
The index rising for the fourth straight session surged 564 points.
Gains were led by index heavyweights with Reliance Industries contributing the most.
Sentiment was hurt after market regulator Sebi directed bourses to initiate action against 331 suspected shell companies.
Investors booked profits in recent gainers
Stocks reeled under huge losses on Thursday as the benchmark Sensex plunged sharply by over 465 points, the biggest single-day fall in three months, after India carried out "surgical strikes" on Wednesday night on terror launch pads across the Line of Control.
How did marquee Dalal Street investors fare in the Jan-Mar quarter that saw the BSE Sensex tank 10 per cent?
The breadth, indicating strength of the market was strong
Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.
The broader NSE Nifty, after cracking below the key 10,300-mark, touched a low of 10,211.25, before finally ending 134.75 points, or 1.30 per cent, down at 10,226.55.
The 30-share Sensex ended higher by 31 points at 26,591 and the 50-share Nifty gained 10 points at 8,061.
The broader NSE Nifty too dived by 101.65 points, or 0.97 per cent, to close at 10,350.15.
On the sectoral map, consumer durables stayed in the lead by surging 2.39 per cent, followed by realty index, oil and gas and infra.
The Nifty rose 176.50 points, or 1.74 per cent, during the week.
Broader gains were capped as investors awaited corporate results from major firms
Foreign portfolio investors were net buyers in equities to the tune of Rs 119 crore, as per provisional stock exchange data.
Reliance Industries, Infosys and Tata Motors were the top contributors
Investors have kept their eyes on US-China trade talks and are optimistic about a positive outcome.
Top corporates have paid more advance tax in second quarter this year.
Sensex lacklustre, bluechips in focus.
Brokerages expect Nifty50 firms to post 11.8% growth in net profit in Q1 but sales may decline
Data also show that several other leading domestic pharma companies have recalled their products from the US
Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.
GVK Biosciences is the latest Indian firm to come under international scrutiny over quality issues.
Sun Pharma was by far the biggest gainer in the Sensex pack, surging 8.13 per cent, followed by Dr Reddy's at 4.92 per cent.
The sentiment got support from better-than-expected earning results by select companies and continuous buying by domestic financial institutions.
FMCG major ITC and private banking major ICICI Bank were the top Sensex losers
Broader markets underperformed indices with BSE Midcap down 0.43% while the Smallcap index fell 0.07%.
The S&P BSE Sensex dropped 207 points to end at 25,230.
With rate cut expectations running high ahead of RBI meet this week, risk appetite improved especially in rate sensitive stocks
The Sensex took less than two years to rally from the 10,000-mark it first hit in February 2006 to double that on that New Year's Eve.
The 50-share NSE Nifty shed some ground to settle at 8,699.40 points, up 40.30 points, or 0.47 per cent
Benchmark share indices ended flat amid lack of investor participation even as gains in IT majors ahead of their second quarter earnings helped capped downside.
Pharma major Lupin and mortgage lender HDFC were the top losers.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances